Solving Enterprise Challenges and Supporting Business Growth — District Mayor Wang Youguo of Daxing District and his delegation visited Minhai Biotechnology for on-site research and guidance.

Release date:

2018-04-28

Author:

Contributed by the General Office

Source:


Abstract

On the afternoon of April 23, 2018, District Mayor Wang Youguo of Daxing District, Beijing, led a delegation to our company for a visit and guidance. Accompanying him were Deputy District Mayor Yang Beibei, Secretary Tian Dexiang of the Biomedical Base Management Committee, Director Hu Baochen of the Daxing District Commission of Economy and Information Technology, and other officials. The company’s Chairman Du Weimin, General Manager Zheng Haifa, Executive Vice General Manager Liu Jiankai, along with leaders from relevant departments, joined the delegation to provide on-site support and guidance.

  On the afternoon of April 23, 2018, District Mayor Wang Youguo of Daxing District, Beijing, led a delegation to our company for a visit and guidance. Accompanying him were Deputy District Mayor Yang Beibei, Secretary Tian Dexiang of the Biomedical Base Management Committee, Director Hu Baochen of the Daxing District Commission of Economy and Information Technology, and other officials. The company was represented by Chairman Du Weimin, General Manager Zheng Haifa, Executive Vice General Manager Liu Jiankai, along with leaders from relevant departments, who joined the inspection and provided guidance.

 

 

  At the research symposium, General Manager Du first extended a warm welcome to the leaders of Daxing District and expressed his gratitude for their ongoing care and support in the company’s growth and development. Company General Manager Zheng Haifa then provided a brief overview of the company’s overall situation, focusing on its basic profile, the competitive advantages of its R&D products, its performance metrics, and prospects for future expansion. District Chief Wang periodically posed targeted questions about Mr. Zheng’s presentation, fully endorsing the company’s R&D achievements and innovative technologies, while also offering on-the-spot solutions to address existing bottlenecks in the company’s development and providing concrete guidance. Following this, General Manager Du gave District Chief Wang a concise briefing on the company’s plans to further accelerate its growth. After hearing the report, District Chief Wang encouraged the company’s leadership team to press ahead with renewed vigor, striving to make further contributions to Daxing’s economic development and to the health and well-being of its people.

 

 

  Following the briefing, District Mayor Wang Youguo of Daxing District, accompanied by the company’s leadership, toured the company’s quality‑control workshop, inspected its state‑of‑the‑art equipment, and inquired about the status of the instruments and their operational performance. He offered constructive guidance on the company’s vaccine R&D, management practices, and future prospects, and pledged to strengthen communication with relevant departments to provide robust support for the enterprise’s rapid growth, thereby ensuring a favorable environment for innovative companies like Minhai.

 

 

  General Manager Du stated that Minhai Biologics’ corporate mission is “to develop the best vaccines and safeguard human health.” As guardians of public health, we are acutely aware of our profound responsibilities and noble mission. We are confident that, with the support of the district government, we can make even greater contributions to the health of our people and to the advancement of the nation’s disease prevention efforts.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09